Since Ontario expanded the scope of practice for pharmacists, more patients are forgoing the waiting room to seek healthcare advice at their local pharmacy. Impetigo is one of many conditions pharmacists can treat. Impetigo is a highly contagious infection in the epidermis or outer layers of the skin, primarily caused by Staphylococci bacteria. This blog offers advice for diagnosing impetigo and offering the right treatment options for patients.
Identifying Impetigo in Patients
There are two forms of impetigo, known as nonbullous and bullous impetigo respectively. Nonbullous impetigo is the most common form, characterized by rupturing blisters. S. aureus is the primary cause, especially in the early stages, but Streptococci bacteria tend to dominate in the later stages.
Bullous impetigo, on the other hand, is caused solely by S. aureus and is most prevalent in infants and children. The bullae, or large fluid-filled blisters, appear as bacteria release toxins. Untreated or unresponsive bullous impetigo may develop into a deep ulcerated infection known as ecthyma.
Some children or adults with pre-existing skin conditions, such as atopic dermatitis, may be more prone to infections. Both forms often appear after a small break in the skin.
Key Clinical Clues of Impetigo
Impetigo may be easily mistaken for other diseases, but a few signs and symptoms can help you identify the condition. Patients may describe a painless itchy rash with red spots progressing to fluid-filled blisters. You may also see:
- Vesicles and pustules on the face, scalp, and hands
- Warm, red skin around the rash
- Thick, golden yellow crusted lesion over a red rash
- Enlarged and tender lymph nodes
- Mild fever
The golden-yellow crust is the tell-tale sign of impetigo. It appears as the blisters rupture and leak yellow pus that dries.
Evidence-Based Treatment for Impetigo
Impetigo often clears with treatment within five days. However, early treatment is essential to prevent scarring, cellulitis, or hyper- or hypopigmentation.
Topical and Oral Antibiotics
Antibiotics are the primary treatment for impetigo. You can prescribe topical or oral antibiotics, though a topical form is as effective for mild or moderate impetigo with fewer side effects. Effective topical antibiotics include:
- Mupirocin cream
- Fusidic acid cream
You may need to combine topical antibiotics with oral for widespread infections, systemic symptoms, or family clusters. Oral antibiotics should cover group A beta-hemolytic Streptococcus and S. aureus. Effective oral medications include:
If your patient has a penicillin allergy, consider the following:
- Sulfamethoxazole trimethoprim
If your community has known cases of MRSA or the rash doesn’t respond to treatment, take a swab to test for culture and sensitivity. Prescribe the oral antibiotics listed above for penicillin allergies with mupirocin cream, Polysporin triple therapy, or ozenoxacin 1% cream.
Impetigo is highly contagious and spreads through direct contact with the rash or contaminated personal items such as bedding, towels, and facecloths. Encourage frequent handwashing with soap and water, and instruct patients to avoid touching their faces or sharing personal items. Covering the skin sores with a dry, sterile dressing can also be helpful in preventing the spread of the bacteria.
Follow-Ups and Monitoring
Encourage patients to return for a follow-up a few days after recommending treatment to ensure that the medication is being used correctly and that the infection is improving. If the patient’s condition worsens or fails to improve, the pharmacist should recommend a follow-up appointment with a primary care provider or dermatologist, who may recommend a different course of treatment.
+ + +
Pharmacists play an important role in the management of impetigo, from the initial identification and diagnosis to prescribing the appropriate treatment. By understanding the symptoms and ensuring proper medication adherence, pharmacists can help prevent the spread of the infection and help patients fully recover.
Share this Article
Think Research’s Pharmapod Adopted in University and Colleges Across Canada to Teach Foundations of Medication Safety
TORONTO, ON – February 27, 2024 – Think Research Corporation (TSXV: THNK) (“TRC” or the “Company“), a company focused on transforming healthcare through digital health
How Pharmapod helps you easily report, analyze and document medication incidents to ensure MedSTEP compliance In an effort to improve medication and patient safety, the
Is improving medication and patient safety a priority for your healthcare organization in 2024? Then you need a medication incident reporting tool that makes it